CTRI/2022/05/042712尚未招募未知
â??Randomized open labeled controlled parallel group add onclinical atudy to assess the efficacy of Shatavaryadi churnaalong with spectacles correction in the managemant of DwitiyaPatalgat Timira with special reference to Presbyopiaâ??
Dr Srishti Vyas0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i)Patients willing to participate in this trial through written informed consent.
- •ii) Patients who are 35 years to 45 years of age and from any sex.
- •iii) Patients having specific symptoms of Dwitiya Patalagata Timira.
- •iv) Emmetropia.
排除标准
- •i)A person with age below 35 years and above 45 years.
- •ii) Presbyopia associated with systemic disorders and ocular pathology.
- •iii) Presbyopia with cataract.
- •iv) Persons with myopia and hypermetropia.
- •v) Persons who are not willing to give their written conset.
研究者
相似试验
尚未招募
不适用
Ayurvedic Management of Rheumatoid ArthritisCTRI/2020/04/024674Dr Ramyashree Nagendra
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleMedDRA version: 20.1Level: LLTClassification code 10016398Term: Female infertilitySystem Organ Class: 100000004872MedDRA version: 21.0Level: LLTClassification code 10016403Term: Female infertility of tubal originSystem Organ Class: 100000004872MedDRA version: 21.1Level: LLTClassification code 10025511Term: Male infertility, unspecifiedSystem Organ Class: 100000004872MedDRA version: 21.0Level: LLTClassification code 10014787Term: Endometriosis of uterusSystem Organ Class: 100000004872MedDRA version: 21.0Level: LLTClassification code 10014784Term: Endometriosis of ovarySystem Organ Class: 100000004872EUCTR2017-002783-40-DKFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleMedDRA version: 20.1 Level: LLT Classification code 10016398 Term: Female infertility System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10016403 Term: Female infertility of tubal origin System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10025511 Term: Male infertility, unspecified System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10014787 Term: Endometriosis of uterus System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10014784 Term: Endometriosis of ovary System Organ Class: 100000004872EUCTR2017-002783-40-NLFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleMedDRA version: 20.1Level: LLTClassification code 10016398Term: Female infertilitySystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10016403Term: Female infertility of tubal originSystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10025511Term: Male infertility, unspecifiedSystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10014787Term: Endometriosis of uterusSystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10014784Term: Endometriosis of ovarySystem Organ Class: 100000004872EUCTR2017-002783-40-NOFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioEUCTR2017-002783-40-ITFerring Pharmaceutical A/S400